Japan Intravenous (IV) Equipments Market Overview, 2031

Japan boasts a highly advanced and well-established healthcare infrastructure. The country is known for its modern hospitals, cutting-edge medical technologies, and a high standard of patient care. This advanced infrastructure includes the use of state-of-the-art IV equipment Japan has one of the world's most rapidly aging populations. With an increasing number of elderly individuals, there is a higher prevalence of chronic diseases that often require intravenous therapies. IV equipment plays a crucial role in delivering medications and nutrients to manage these conditions. There is a cultural emphasis on patient-centric care in Japan. This involves tailoring healthcare services to meet individual patient needs and preferences. IV equipment is selected and used with a focus on providing the best possible care experience for each patient. According to a 2022 report from the Japanese Ministry of Health, Labour and Welfare, there were an estimated 1.4 million people in Japan who used intravenous (IV) equipment in the past year. This number has been steadily increasing in recent years, as more and more people are diagnosed with chronic diseases that require IV therapy. The most common conditions requiring IV therapy in Japan are cancer, heart disease, and diabetes. Japan has a high standard of healthcare, and IV equipment is considered to be a critical medical device. This means that the government imposes strict regulations on the quality and safety of IV equipment, which can drive up the cost. This can create a situation where there is less competition in the IV equipment market, which can also drive up prices. An IV pump can cost approximately US$ 85, while a common IV catheter can cost more than US$3.

According to the research report, "Japan Intravenous Equipment Market Overview, 2031," published by Bonafide Research, the Japan Intravenous Equipment market is anticipated to add to more than 320 Million by 2026–31.Japan is known for its commitment to technological innovation. In the IV equipment market, this translates to the development and adoption of advanced technologies, such as smart pumps, infusion monitoring systems, and devices with enhanced safety features. Patient safety is a top priority in the Japanese healthcare system. IV equipment in Japan is designed and used with a strong emphasis on safety standards, including features to prevent medication errors, infection control measures, and continuous monitoring capabilities. There has been a gradual shift towards the use of disposable IV systems in Japan. Disposable IV sets and components are preferred for their convenience, reduced risk of contamination, and ease of disposal. Smart infusion pumps with features such as dose error reduction systems (DERS), wireless connectivity, and integration with electronic medical records (EMRs) are becoming more prevalent in Japan. These pumps enhance accuracy, reduce medication errors, and improve workflow efficiency. The COVID-19 pandemic has accelerated the adoption of telemedicine in Japan. This trend includes the use of remote monitoring solutions integrated with IV equipment, allowing healthcare providers to track patients' conditions and adjust treatments remotely. For patients requiring insulin therapy or glucose control, there is a trend toward the integration of IV equipment with continuous blood glucose monitoring systems.

In the Japan intravenous (IV) equipment market, the product landscape blends essential consumables with advancing technology, reflecting a healthcare system that emphasizes precision, safety, and patient comfort. At the forefront of this market are IV catheters, which lead in usage and form the foundation of virtually all IV therapies. In Japan, peripheral catheters dominate within this segment, accounting for the largest revenue share because they are widely used across hospitals, emergency departments, and outpatient services for routine fluid and medication delivery. Central venous catheters, while smaller by volume, are the fastest growing sub segment as Japan’s healthcare facilities increasingly manage complex, long term treatments that require stable, deep venous access. This dynamic underscores the central role catheters play in both everyday care and specialized clinical procedures, driven by the country’s aging population and rising demand for therapies such as oncology, critical care, and chronic disease management. IV infusion pumps are another crucial product type, ranking just behind catheters in importance and market value. In Japan, infusion pumps have seen robust uptake, with the market for these devices generating significant revenue and demonstrating strong growth as healthcare providers adopt more precise and technologically advanced solutions. Volumetric infusion pumps represent the largest share within this category, widely used for controlled drug delivery in intensive care, anesthesia, oncology, and pediatric care. Meanwhile, segments such as insulin infusion pumps are among the fastest growing, reflecting broader trends toward personalized and chronic care management.

Hospitals and clinics, including dialysis centers, dominate the market, accounting for the largest share of IV equipment utilization due to their central role in providing comprehensive care. This segment serves a wide range of clinical needs from emergency interventions and surgeries to long term treatments such as chemotherapy and chronic disease management making it the principal driver of demand for IV devices. Japan’s well developed hospital infrastructure ensures that essential IV products such as catheters, infusion pumps, and administration sets are continuously utilized in high volumes to support both acute and routine therapies. Dialysis centers also play a significant role, as the country’s aging population and higher prevalence of chronic kidney conditions require repeated and long duration treatments that depend on reliable IV access and precise fluid management systems. Ambulatory surgical centers (ASCs) are an emerging application segment in Japan, reflecting the global trend toward outpatient and day care procedures. While still smaller in total usage compared to hospitals, the ASC segment is gaining momentum as healthcare delivery expands beyond traditional inpatient environments. Home care settings are also becoming increasingly important, fueled by demographic shifts such as a growing elderly population and a rise in chronic diseases that benefit from at home IV therapies. In Japan, home based IV care including hydration therapy, antibiotic infusions, and nutritional support has seen uptake thanks to compact infusion pumps and user friendly catheter systems that make safe, remote management possible.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Intravenous Equipments Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• IV Catheters
• IV Infusion Pumps
• IV Securement Devices
• IV Administration Sets & Solutions
• IV Needles & Syringes
• Stopcocks & Check Valves
• Others

By Application
• Hospitals & Clinics/Dialysis Centers
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Others